6
7
Introduction to Revitive
Indications for use
When using the foot-pads, Revitive is intended to:
• Improve circulation to reduce or prevent blood-pooling (stasis) - caused by
poor circulation due to a sedentary lifestyle or long periods of sitting or
standing.
• Help maintain leg vein health - by increasing circulation, delivering more
oxygenated blood in the legs, feet & ankles
When using the body pads applied to the legs, Revitive is
intended to:
• Increase muscle strength to help regain mobility in the legs aected by being
immobile due to COPD, osteoarthritis or following surgery.
The above Indications for Use are certified under the Medical Devices Directive
93/42/EEC.
In addition, if you have a sedentary lifestyle or spend long periods inactive, Revitive
may help to:
• Reduce foot & leg discomfort
• Actively increase circulation.
Read all instructions before use
Who should not use Revitive
Revitive should NOT be used by some people.
DO NOT USE IF (contraindications):
• You are fitted with an electronic implanted device such as a heart pacemaker
or Automatic Implantable Cardioverter Defibrillator (AICD)
• You are pregnant
• You are being treated for, or have the symptoms of, an existing Deep Vein
Thrombosis (“DVT”)
Long periods of inactivity can put you at greater risk of developing Deep
Vein Thrombosis (DVT). DVT is a blood clot and usually occurs in a deep
leg vein. If part of the DVT breaks o it may lead to potentially life-
threatening complications such as pulmonary embolism.
If you have been inactive for prolonged periods and suspect you may
have a DVT, consult your doctor immediately. To prevent dislodging the
clot do not use Revitive.
In some cases of DVT there may be no symptoms. However it is important
to be aware of the symptoms that may include:
• pain, swelling and tenderness in one of your legs (usually your calf)
• a heavy ache in the aected area
• warm skin in the area of the clot
• redness of your skin, particularly at the back of your leg, below
the knee
Consult your doctor as soon as possible if you show any signs of the
above symptoms.
Important Safeguards
EN
5827_IFU04_17963935.indd 7
5827_IFU04_17963935.indd 7
09/04/2021 13:23
To Next Page
Loading...
